Medicare and Medicaid Programs; Application From the Joint Commission (TJC) for Continued Approval of Its Home Health Agency Accreditation Program, 18245-18247 [2020-06792]
Download as PDF
Federal Register / Vol. 85, No. 63 / Wednesday, April 1, 2020 / Notices
IV. Provisions of the Final Notice
A. Differences Between URAC’s
Standards and Requirements for
Accreditation and Medicare Conditions
and Survey Requirements
We compared URAC’s HIT
accreditation requirements and survey
process with the Medicare CfCs of part
486, subpart I and the survey and
certification process requirements of
part 488, subpart L. Our review and
evaluation of URAC’s HIT application,
which was conducted as described in
section III. of this final notice, yielded
the following areas where, as of the date
of this notice, URAC has completed
revising its standards and certification
processes in order to meet the condition
at:
• § 486.520(a), to address the
requirement stating all patients must be
under the care of an applicable
provider.
• § 488.1010(a)(5), to provide a
detailed crosswalk identifying the exact
language of the organization’s
comparable accreditation requirements
and standards.
• § 488.1010(a)(6)(ix), to revise
URAC’s procedures for ‘‘immediate
jeopardy’’ situations.
• § 488.1010(a)(6)(iv), to revise
URAC’s survey procedures for surveys.
• § 488.1010(a)(6)(v), to revise
URAC’s procedures and timelines for
notifying a surveyed or audited home
infusion therapy supplier of noncompliance with the home infusion
therapy accreditation program’s
standards.
• § 488.1010(a)(6)(vi), to revise
URAC’s procedures and timelines for
monitoring the home infusion therapy
supplier’s correction of identified noncompliance with the accreditation
program’s standards.
• § 489.13, to reflect our policies
regarding when the effective period of
an accreditation begins and ends
jbell on DSKJLSW7X2PROD with NOTICES
B. Term of Approval
Based on the review and observations
described in section III. of this final
notice, we have determined that URAC’s
requirements for HITs meet or exceed
our requirements. Therefore, we
approve URAC as a national
accreditation organization for HITs that
request participation in the Medicare
program, effective March 27, 2020
through March 27, 2024.
IV. Collection of Information
Requirements
This document does not impose
information collection and
requirements, that is, reporting,
recordkeeping or third party disclosure
VerDate Sep<11>2014
18:31 Mar 31, 2020
Jkt 250001
requirements. Consequently, there is no
need for review by the Office of
Management and Budget under the
authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. Chapter 35).
The Administrator of the Centers for
Medicare & Medicaid Services (CMS),
Seema Verma, having reviewed and
approved this document, is delegating
the authority to electronically sign this
document to Evell J. Barco Holland,
who is the Federal Register Liaison, for
purposes of publication in the Federal
Register.
Dated: March 26, 2020.
Evell J. Barco Holland,
Federal Register Liaison, Department of
Health and Human Services.
[FR Doc. 2020–06795 Filed 3–31–20; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3384–FN]
Medicare and Medicaid Programs;
Application From the Joint
Commission (TJC) for Continued
Approval of Its Home Health Agency
Accreditation Program
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Final notice.
AGENCY:
This final notice announces
our decision to approve The Joint
Commission (TJC) for continued
recognition as a national accrediting
organization for home health agencies
(HHAs) that wish to participate in the
Medicare or Medicaid programs. A HHA
that participates in Medicaid must also
meet the Medicare conditions of
participation (CoPs).
DATES: The decision announced in this
final notice is effective March 31, 2020
through March 31, 2026.
FOR FURTHER INFORMATION CONTACT:
Sharon Lash (410) 786–9457.
Caecilia Blondiaux (410) 786–2190.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background
Under the Medicare program, eligible
beneficiaries may receive covered
services from a home health agency
(HHA), provided that certain
requirements are met. Sections 1861(m)
and (o), 1891 and 1895 of the Social
Security Act (the Act) establish distinct
criteria for an entity seeking designation
as an HHA. Regulations concerning
provider agreements are at 42 CFR part
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
18245
489 and those pertaining to activities
relating to the survey and certification
of facilities and other entities are at 42
CFR part 488. The regulations at 42 CFR
parts 409 and 484 specify the conditions
that an HHA must meet to participate in
the Medicare program, the scope of
covered services and the conditions for
Medicare payment for home health care.
Generally, to enter into a provider
agreement with the Medicare program,
an HHA must first be certified by a state
survey agency as complying with the
conditions or requirements set forth in
42 CFR part 484 of our regulations.
Thereafter, the HHA is subject to regular
surveys by a state survey agency to
determine whether it continues to meet
these requirements. However, there is
an alternative to certification surveys by
state agencies. Accreditation by a
nationally recognized Medicare
accreditation program approved by CMS
may substitute for both initial and
ongoing state review.
Section 1865(a)(1) of the Act provides
that, if a provider entity demonstrates
through accreditation by an approved
national accrediting organization that all
applicable Medicare conditions are met
or exceeded, we will deem those
provider entities as having met our
requirements. Accreditation by an
accrediting organization is voluntary
and is not required for Medicare
participation.
If an accrediting organization is
recognized by the Secretary of Health
and Human Services as having
standards for accreditation that meet or
exceed Medicare requirements, any
provider entity accredited by the
national accrediting body’s approved
program would be deemed to meet the
Medicare conditions. A national
accrediting organization applying for
CMS approval of their accreditation
program under 42 CFR part 488, subpart
A must provide CMS with reasonable
assurance that the accrediting
organization requires the accredited
provider entities to meet requirements
that are at least as stringent as the
Medicare conditions. Our regulations
concerning the approval of accrediting
organizations are set forth at § 488.5.
Section 488.5(e)(2)(i) requires
accrediting organizations to reapply for
continued approval of its Medicare
accreditation program every 6 years or
sooner as determined by CMS.
The Joint Commission’s (TJC’s) term
of approval for their HHA accreditation
program expires March 31, 2020.
II. Application Approval Process
Section 1865(a)(3)(A) of the Act
provides a statutory timetable to ensure
that our review of applications for CMS-
E:\FR\FM\01APN1.SGM
01APN1
18246
Federal Register / Vol. 85, No. 63 / Wednesday, April 1, 2020 / Notices
jbell on DSKJLSW7X2PROD with NOTICES
approval of an accreditation program is
conducted in a timely manner. The Act
provides us 210 days after the date of
receipt of a complete application, with
any documentation necessary to make
the determination, to complete our
survey activities and application
process. Within 60 days after receiving
a complete application, we must
publish a notice in the Federal Register
that identifies the national accrediting
body making the request, describes the
request, and provides no less than a 30day public comment period. At the end
of the 210-day period, we must publish
a notice in the Federal Register
approving or denying the application.
III. Provisions of the Proposed Notice
In the October 24, 2019 Federal
Register (84 FR 57026), we published a
proposed notice announcing TJC’s
request for continued approval of its
Medicare HHA accreditation program.
In the October 24, 2019 proposed notice,
we detailed our evaluation criteria.
Under section 1865(a)(2) of the Act and
in our regulations at § 488.5, we
conducted a review of TJC’s Medicare
HHA accreditation application in
accordance with the criteria specified by
our regulations, which include, but are
not limited to the following:
• An onsite administrative review of
TJC’s: (1) Corporate policies; (2)
financial and human resources available
to accomplish the proposed surveys; (3)
procedures for training, monitoring, and
evaluation of its HHA surveyors; (4)
ability to investigate and respond
appropriately to complaints against
accredited HHAs; and (5) survey review
and decision-making process for
accreditation.
• The comparison of TJC’s Medicare
HHA accreditation program standards to
our current Medicare HHA CoPs.
• A documentation review of TJC’s
survey process to do the following:
++ Determine the composition of the
survey team, surveyor qualifications,
and TJC’s ability to provide continuing
surveyor training.
++ Compare TJC’s processes to those
we require of state survey agencies,
including periodic resurvey and the
ability to investigate and respond
appropriately to complaints against
accredited HHAs.
++ Evaluate TJC’s procedures for
monitoring HHAs it has found to be out
of compliance with TJC’s program
requirements. (This pertains only to
monitoring procedures when TJC
identifies non-compliance. If
noncompliance is identified by a state
survey agency through a validation
survey, the state survey agency monitors
corrections as specified at § 488.9(c)).
VerDate Sep<11>2014
18:31 Mar 31, 2020
Jkt 250001
++ Assess TJC’s ability to report
deficiencies to the surveyed HHAs and
respond to the HHAs plan of correction
in a timely manner.
++ Establish TJC’s ability to provide
CMS with electronic data and reports
necessary for effective validation and
assessment of the organization’s survey
process.
++ Determine the adequacy of TJC’s
staff and other resources.
++ Confirm TJC’s ability to provide
adequate funding for performing
required surveys.
++ Confirm TJC’s policies with
respect to surveys being unannounced.
++ Confirm TJC’s policies and
procedures to avoid conflicts of interest,
including the appearance of conflicts of
interest, involving individuals who
conduct surveys or participate in
accreditation decisions.
++ Obtain TJC’s agreement to provide
CMS with a copy of the most current
accreditation survey together with any
other information related to the survey
as we may require, including corrective
action plans.
In accordance with section
1865(a)(3)(A) of the Act, the October 24,
2019 proposed notice also solicited
public comments regarding whether
TJC’s requirements met or exceeded the
Medicare CoPs for HHA. No comments
were received in response to our
proposed notice.
IV. Provisions of the Final Notice
A. Differences Between TJC’s Standards
and Requirements for Accreditation and
Medicare Conditions and Survey
Requirements
We compared TJC’s HHA
accreditation requirements and survey
process with the Medicare CoPs of parts
409 and 484, and the survey and
certification process requirements of
parts 488 and 489. Our review and
evaluation of TJC’s HHA application,
which were conducted as described in
section III. of this final notice, yielded
the following areas where, as of the date
of this notice, TJC has completed
revising its standards and certification
processes in order to do all of the
following:
• Meet the requirements of all of the
following regulations:
++ Section 484.45 to address that
HHAs must electronically report all
OASIS data collected in accordance
with § 484.55.
++ Section 484.50 to include
language referencing patient
representatives, to be included within
the ‘‘Patient Rights’’ condition of
participation.
++ Section 484.50(a)(1)(i) to
incorporate language related to the right
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
of persons who have limited English
proficiency and individuals with
disabilities to receive understandable,
accessible communications.
++ Section 484.50(c)(11) to include
the patient’s rights to voice grievances
to an outside entity.
++ Section 484.50(d)(1) to address
safe and appropriate transfer of patients.
++ Section 484.50(e)(2) to include
reporting of injuries of unknown source,
or misappropriation of patient property.
++ Section 484.60 to address
‘‘individualized’’ and ‘‘patient-specific’’
plans of care, specifically that the
individualized plan of care must specify
the care and services necessary to meet
the patient-specific needs as identified
in the comprehensive assessment,
including identification of the
responsible discipline(s), and the
measurable outcomes that the HHA
anticipates will occur as a result of
implementing and coordinating the plan
of care.
++ Section 484.60(b)(4) to address
that stamped signatures are not
acceptable unless used in a case of an
author with a physical disability that
can provide proof to a CMS contractor
of his/her inability to sign their
signature due to their disability
(Rehabilitation Act of 1973).
++ Section 484.80(g)(1) to include
professions of physical therapist,
speech-language pathologist, or
occupational therapist professions in
any of their standards where
‘‘appropriate skilled professional’’ is
found in the regulatory language.
++ Section 484.105(h)(2)(i) and
484.105(h)(2)(ii)(B) to include that
transactions that are separated in time,
but are components of an overall plan
or patient care objective, are viewed in
their entirety without regard to their
timing and to include section 1122 of
the Act (42 U.S.C. 1320a–1) and
implementing regulations.
++ Section 484.115(a)(1) to address
citable standards to this CoP regarding
HHA administrators.
• Provide clarifications and training
to surveyors related to the verification of
written documentation of the facility’s
emergency preparedness program as
required under § 484.102.
• Provide training to TJC surveyors
related to report gathering, specifically
the requirements for CASPER and
OASIS reports.
• Make changes to the amount of
detail provided to the facility during
TJC’s daily briefing to ensure tracer
methodology does not change the
integrity of the survey process.
• Remove previous references to the
educational and consultative nature of
TJC’s services when TJC is conducting
E:\FR\FM\01APN1.SGM
01APN1
Federal Register / Vol. 85, No. 63 / Wednesday, April 1, 2020 / Notices
surveys, particularly during
communications with the facility.
Accrediting organization survey
processes should emphasize facility
compliance with Medicare’s health and
safety standards, rather than any
educational function.
B. Term of Approval
Based on our review and observations
described in section III. of this final
notice, we approve TJC as a national
accreditation organization for HHAs that
request participation in the Medicare
program. The decision announced in
this final notice is effective March 31,
2020 through March 31, 2026.
V. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is, reporting recordkeeping or thirdparty disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
The Administrator of the Centers for
Medicare & Medicaid Services (CMS),
Seema Verma, having reviewed and
approved this document, is delegating
the authority to electronically sign this
document to Evell J. Barco Holland,
who is the Federal Register Liaison, for
purposes of publication in the Federal
Register.
Dated: March 26, 2020.
Evell J. Barco Holland,
Federal Register Liaison, Department of
Health and Human Services.
[FR Doc. 2020–06792 Filed 3–31–20; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2020–D–1057]
Notifying the Food and Drug
Administration of a Permanent
Discontinuance or Interruption in
Manufacturing Under Section 506C of
the Federal Food, Drug, and Cosmetic
Act; Guidance for Industry; Availability
AGENCY:
Food and Drug Administration,
HHS.
jbell on DSKJLSW7X2PROD with NOTICES
ACTION:
Notice of availability.
The Food and Drug
Administration (FDA or Agency) is
announcing the availability of a
guidance for industry entitled
‘‘Notifying FDA of a Permanent
Discontinuance or Interruption in
SUMMARY:
VerDate Sep<11>2014
18:31 Mar 31, 2020
Jkt 250001
Manufacturing Under Section 506C of
the FD&C Act.’’ Due to the Coronavirus
Disease 2019 (COVID–19) pandemic,
FDA has been closely monitoring the
medical product supply chain with the
expectation that it may be impacted by
the COVID–19 outbreak, potentially
leading to supply disruptions or
shortages of drug and biological
products in the United States. The
guidance is intended to assist applicants
and manufacturers in providing FDA
timely, informative notifications about
changes in the production of certain
drugs and biological products that will,
in turn, help the Agency in its efforts to
prevent or mitigate shortages of such
products. Given the public health
emergency presented by COVID–19, this
guidance document is being
implemented without prior public
comment because FDA has determined
that prior public participation is not
feasible or appropriate, but it remains
subject to comment in accordance with
the Agency’s good guidance practices.
In addition, this guidance is intended to
remain in effect for the duration of the
public health emergency related to
COVID–19 declared by the Department
of Health and Human Services (HHS).
However, the recommendations and
processes described in the guidance are
expected to assist the Agency more
broadly in its efforts to prevent and
mitigate shortages, including under
circumstances outside of the COVID–19
public health emergency and reflect the
Agency’s current thinking on this issue.
Therefore, within 60 days following the
termination of the public health
emergency, FDA intends to revise and
replace this guidance with any
appropriate changes following the
public health emergency and in
consideration of comments received on
this guidance and the Agency’s
experience with implementation.
DATES: The announcement of the
guidance is published in the Federal
Register on April 1, 2020. The guidance
document is immediately in effect, but
it remains subject to comment in
accordance with the Agency’s good
guidance practices.
ADDRESSES: You may submit comments
on any guidance at any time as follows:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
18247
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Dockets
Management Staff (HFA–305), Food and
Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Dockets Management
Staff, FDA will post your comment, as
well as any attachments, except for
information submitted, marked and
identified, as confidential, if submitted
as detailed in ‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2020–D–1057 for ‘‘Notifying FDA of a
Permanent Discontinuance or
Interruption in Manufacturing Under
Section 506C of the FD&C Act.’’
Received comments will be placed in
the docket and, except for those
submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
E:\FR\FM\01APN1.SGM
01APN1
Agencies
[Federal Register Volume 85, Number 63 (Wednesday, April 1, 2020)]
[Notices]
[Pages 18245-18247]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-06792]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3384-FN]
Medicare and Medicaid Programs; Application From the Joint
Commission (TJC) for Continued Approval of Its Home Health Agency
Accreditation Program
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Final notice.
-----------------------------------------------------------------------
SUMMARY: This final notice announces our decision to approve The Joint
Commission (TJC) for continued recognition as a national accrediting
organization for home health agencies (HHAs) that wish to participate
in the Medicare or Medicaid programs. A HHA that participates in
Medicaid must also meet the Medicare conditions of participation
(CoPs).
DATES: The decision announced in this final notice is effective March
31, 2020 through March 31, 2026.
FOR FURTHER INFORMATION CONTACT:
Sharon Lash (410) 786-9457.
Caecilia Blondiaux (410) 786-2190.
SUPPLEMENTARY INFORMATION:
I. Background
Under the Medicare program, eligible beneficiaries may receive
covered services from a home health agency (HHA), provided that certain
requirements are met. Sections 1861(m) and (o), 1891 and 1895 of the
Social Security Act (the Act) establish distinct criteria for an entity
seeking designation as an HHA. Regulations concerning provider
agreements are at 42 CFR part 489 and those pertaining to activities
relating to the survey and certification of facilities and other
entities are at 42 CFR part 488. The regulations at 42 CFR parts 409
and 484 specify the conditions that an HHA must meet to participate in
the Medicare program, the scope of covered services and the conditions
for Medicare payment for home health care.
Generally, to enter into a provider agreement with the Medicare
program, an HHA must first be certified by a state survey agency as
complying with the conditions or requirements set forth in 42 CFR part
484 of our regulations. Thereafter, the HHA is subject to regular
surveys by a state survey agency to determine whether it continues to
meet these requirements. However, there is an alternative to
certification surveys by state agencies. Accreditation by a nationally
recognized Medicare accreditation program approved by CMS may
substitute for both initial and ongoing state review.
Section 1865(a)(1) of the Act provides that, if a provider entity
demonstrates through accreditation by an approved national accrediting
organization that all applicable Medicare conditions are met or
exceeded, we will deem those provider entities as having met our
requirements. Accreditation by an accrediting organization is voluntary
and is not required for Medicare participation.
If an accrediting organization is recognized by the Secretary of
Health and Human Services as having standards for accreditation that
meet or exceed Medicare requirements, any provider entity accredited by
the national accrediting body's approved program would be deemed to
meet the Medicare conditions. A national accrediting organization
applying for CMS approval of their accreditation program under 42 CFR
part 488, subpart A must provide CMS with reasonable assurance that the
accrediting organization requires the accredited provider entities to
meet requirements that are at least as stringent as the Medicare
conditions. Our regulations concerning the approval of accrediting
organizations are set forth at Sec. 488.5. Section 488.5(e)(2)(i)
requires accrediting organizations to reapply for continued approval of
its Medicare accreditation program every 6 years or sooner as
determined by CMS.
The Joint Commission's (TJC's) term of approval for their HHA
accreditation program expires March 31, 2020.
II. Application Approval Process
Section 1865(a)(3)(A) of the Act provides a statutory timetable to
ensure that our review of applications for CMS-
[[Page 18246]]
approval of an accreditation program is conducted in a timely manner.
The Act provides us 210 days after the date of receipt of a complete
application, with any documentation necessary to make the
determination, to complete our survey activities and application
process. Within 60 days after receiving a complete application, we must
publish a notice in the Federal Register that identifies the national
accrediting body making the request, describes the request, and
provides no less than a 30-day public comment period. At the end of the
210-day period, we must publish a notice in the Federal Register
approving or denying the application.
III. Provisions of the Proposed Notice
In the October 24, 2019 Federal Register (84 FR 57026), we
published a proposed notice announcing TJC's request for continued
approval of its Medicare HHA accreditation program. In the October 24,
2019 proposed notice, we detailed our evaluation criteria. Under
section 1865(a)(2) of the Act and in our regulations at Sec. 488.5, we
conducted a review of TJC's Medicare HHA accreditation application in
accordance with the criteria specified by our regulations, which
include, but are not limited to the following:
An onsite administrative review of TJC's: (1) Corporate
policies; (2) financial and human resources available to accomplish the
proposed surveys; (3) procedures for training, monitoring, and
evaluation of its HHA surveyors; (4) ability to investigate and respond
appropriately to complaints against accredited HHAs; and (5) survey
review and decision-making process for accreditation.
The comparison of TJC's Medicare HHA accreditation program
standards to our current Medicare HHA CoPs.
A documentation review of TJC's survey process to do the
following:
++ Determine the composition of the survey team, surveyor
qualifications, and TJC's ability to provide continuing surveyor
training.
++ Compare TJC's processes to those we require of state survey
agencies, including periodic resurvey and the ability to investigate
and respond appropriately to complaints against accredited HHAs.
++ Evaluate TJC's procedures for monitoring HHAs it has found to be
out of compliance with TJC's program requirements. (This pertains only
to monitoring procedures when TJC identifies non-compliance. If
noncompliance is identified by a state survey agency through a
validation survey, the state survey agency monitors corrections as
specified at Sec. 488.9(c)).
++ Assess TJC's ability to report deficiencies to the surveyed HHAs
and respond to the HHAs plan of correction in a timely manner.
++ Establish TJC's ability to provide CMS with electronic data and
reports necessary for effective validation and assessment of the
organization's survey process.
++ Determine the adequacy of TJC's staff and other resources.
++ Confirm TJC's ability to provide adequate funding for performing
required surveys.
++ Confirm TJC's policies with respect to surveys being
unannounced.
++ Confirm TJC's policies and procedures to avoid conflicts of
interest, including the appearance of conflicts of interest, involving
individuals who conduct surveys or participate in accreditation
decisions.
++ Obtain TJC's agreement to provide CMS with a copy of the most
current accreditation survey together with any other information
related to the survey as we may require, including corrective action
plans.
In accordance with section 1865(a)(3)(A) of the Act, the October
24, 2019 proposed notice also solicited public comments regarding
whether TJC's requirements met or exceeded the Medicare CoPs for HHA.
No comments were received in response to our proposed notice.
IV. Provisions of the Final Notice
A. Differences Between TJC's Standards and Requirements for
Accreditation and Medicare Conditions and Survey Requirements
We compared TJC's HHA accreditation requirements and survey process
with the Medicare CoPs of parts 409 and 484, and the survey and
certification process requirements of parts 488 and 489. Our review and
evaluation of TJC's HHA application, which were conducted as described
in section III. of this final notice, yielded the following areas
where, as of the date of this notice, TJC has completed revising its
standards and certification processes in order to do all of the
following:
Meet the requirements of all of the following regulations:
++ Section 484.45 to address that HHAs must electronically report
all OASIS data collected in accordance with Sec. 484.55.
++ Section 484.50 to include language referencing patient
representatives, to be included within the ``Patient Rights'' condition
of participation.
++ Section 484.50(a)(1)(i) to incorporate language related to the
right of persons who have limited English proficiency and individuals
with disabilities to receive understandable, accessible communications.
++ Section 484.50(c)(11) to include the patient's rights to voice
grievances to an outside entity.
++ Section 484.50(d)(1) to address safe and appropriate transfer of
patients.
++ Section 484.50(e)(2) to include reporting of injuries of unknown
source, or misappropriation of patient property.
++ Section 484.60 to address ``individualized'' and ``patient-
specific'' plans of care, specifically that the individualized plan of
care must specify the care and services necessary to meet the patient-
specific needs as identified in the comprehensive assessment, including
identification of the responsible discipline(s), and the measurable
outcomes that the HHA anticipates will occur as a result of
implementing and coordinating the plan of care.
++ Section 484.60(b)(4) to address that stamped signatures are not
acceptable unless used in a case of an author with a physical
disability that can provide proof to a CMS contractor of his/her
inability to sign their signature due to their disability
(Rehabilitation Act of 1973).
++ Section 484.80(g)(1) to include professions of physical
therapist, speech-language pathologist, or occupational therapist
professions in any of their standards where ``appropriate skilled
professional'' is found in the regulatory language.
++ Section 484.105(h)(2)(i) and 484.105(h)(2)(ii)(B) to include
that transactions that are separated in time, but are components of an
overall plan or patient care objective, are viewed in their entirety
without regard to their timing and to include section 1122 of the Act
(42 U.S.C. 1320a-1) and implementing regulations.
++ Section 484.115(a)(1) to address citable standards to this CoP
regarding HHA administrators.
Provide clarifications and training to surveyors related
to the verification of written documentation of the facility's
emergency preparedness program as required under Sec. 484.102.
Provide training to TJC surveyors related to report
gathering, specifically the requirements for CASPER and OASIS reports.
Make changes to the amount of detail provided to the
facility during TJC's daily briefing to ensure tracer methodology does
not change the integrity of the survey process.
Remove previous references to the educational and
consultative nature of TJC's services when TJC is conducting
[[Page 18247]]
surveys, particularly during communications with the facility.
Accrediting organization survey processes should emphasize facility
compliance with Medicare's health and safety standards, rather than any
educational function.
B. Term of Approval
Based on our review and observations described in section III. of
this final notice, we approve TJC as a national accreditation
organization for HHAs that request participation in the Medicare
program. The decision announced in this final notice is effective March
31, 2020 through March 31, 2026.
V. Collection of Information Requirements
This document does not impose information collection requirements,
that is, reporting recordkeeping or third-party disclosure
requirements. Consequently, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.).
The Administrator of the Centers for Medicare & Medicaid Services
(CMS), Seema Verma, having reviewed and approved this document, is
delegating the authority to electronically sign this document to Evell
J. Barco Holland, who is the Federal Register Liaison, for purposes of
publication in the Federal Register.
Dated: March 26, 2020.
Evell J. Barco Holland,
Federal Register Liaison, Department of Health and Human Services.
[FR Doc. 2020-06792 Filed 3-31-20; 8:45 am]
BILLING CODE 4120-01-P